Vandetanib‐associated alopecia areata in a patient with metastatic medullary thyroid cancer

E-ISSN： 1365-4632|54|6|e213-e216

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.54, Iss.6, 2015-06, pp. : e213-e216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vandetanib for aggressive and symptomatic medullary thyroid cancer

By Deshpande Hari A Carling Tobias Khan Nabeela Holt Elizabeth

Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. : 275-282

Future Medicine

Access to resources Recommend Favorite

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

By Grande Enrique Kreissl Michael Filetti Sebastiano Newbold Kate Reinisch Walter Robert Caroline Schlumberger Martin Tolstrup Lærke Zamorano Jose Capdevila Jaume

Advances in Therapy, Vol. 30, Iss. 11, 2013-11 ,pp. : 945-966

Springer Publishing Company

Access to resources Recommend Favorite

Medical management of metastatic medullary thyroid cancer

CANCER, Vol. 120, Iss. 21, 2014-11 ,pp. : 3287-3301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastatic medullary thyroid carcinoma to the breast in a patient with combined medullary and papillary carcinoma of thyroid—A case report

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 4, 2015-04 ,pp. : 343-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

The global burden of disease associated with alopecia areata

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1424-1426

John Wiley & Sons Inc

Access to resources Recommend Favorite